Mark D. Tattoli - Jul 2, 2021 Form 4/A - Amendment Insider Report for CORE LABORATORIES N V (CLB)

Role
SVP, Gen Counsel & Secretary
Signature
/s/ Mark Tattoli
Stock symbol
CLB
Transactions as of
Jul 2, 2021
Transactions value $
-$5,877
Form type
4/A - Amendment
Date filed
10/6/2021, 06:51 PM
Date Of Original Report
Oct 5, 2021
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLB Common Shares Options Exercise $0 +120 +3.57% $0.00 3.48K Aug 1, 2021 Direct
transaction CLB Common Shares Tax liability -$967 -29 -0.83% $33.36* 3.45K Aug 1, 2021 Direct
transaction CLB Common Shares Other $0 +1.08 +0.03% $0.00 3.45K Aug 24, 2021 Direct F1
transaction CLB Common Shares Options Exercise $0 +700 +20.27% $0.00 4.15K Oct 1, 2021 Direct
transaction CLB Common Shares Tax liability -$4.91K -169 -4.07% $29.05* 3.98K Oct 1, 2021 Direct
holding CLB Common Shares 20 Jul 2, 2021 Custodial account
holding CLB Common Shares 1.69K Jul 2, 2021 401 (k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Restricted Shares Options Exercise $0 -700 -8.05% $0.00 8K Oct 1, 2021 Common Shares 700 Direct F2
transaction CLB Restricted Shares Award $0 +1.5K +20.83% $0.00 8.7K Aug 1, 2021 Common Shares 1.5K Direct F3
transaction CLB Restricted Shares Options Exercise $0 -120 -1.64% $0.00 7.2K Aug 1, 2021 Common Shares 120 Direct F4
transaction CLB Restricted Shares Award $0 +7.32K $0.00 7.32K Jul 2, 2021 Common Shares 7.32K Direct F5
transaction CLB Performance Shares Award $0 +6.9K $0.00 6.9K Jul 2, 2021 Common Shares 6.9K Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through a broker-sponsored dividend reinvestment plan.
F2 Represents the time-based vesting of 700 shares from a grant of 4,200 Restricted Shares awarded to Mr. Tattoli on October 1, 2020. The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date.
F3 The Restricted Shares granted will vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date.
F4 Represents the time-based vesting of 120 shares from a grant of 720 Restricted Shares awarded to Mr. Tattoli on August 1, 2018. The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date.
F5 Mr. Tattoli has 6 grants of Restricted Shares outstanding as of July 2, 2021, and of those the following shares remain unvested as of such date: 110 shares from the grant on March 1, 2016, 480 shares from the grant on December 1, 2017, 480 shares from the grant on August 1, 2018, 800 shares from the grant on May 1, 2019, 1,250 shares from the grant on May 1, 2020, and 4,200 shares from the grant on October 1, 2020. The Restricted Shares granted will vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date.
F6 Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, this award would vest at the end of a three-year performance period that began on January 1, 2021 and ends on December 31, 2023 (the "Performance Period"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 75th percentile of Return On Invested Capital of the Bloomberg Peer Group as measured and determined by the Compensation Committee at the end of the Performance Period.

Remarks:

The original Form 4 filed on October 5, 2021 is being amended by this Form 4 amendment to correct the number of Common Shares directly held by Mr. Tattoli as of the date of this amended filing. The original Form 4 failed to include (i) the acquisition of 1.082 shares pursuant to a broker-sponsored dividend reinvestment plan and (ii) the time-based vesting of 120 shares on August 1, 2021 in connection with a grant of Restricted Shares on August 1, 2018. The number of unvested Restricted Shares held by Mr. Tattoli as of July 2, 2021 subject to time-based vesting was underreported by 120 shares due to an administrative error. Mr. Tattoli held 7,320 Restricted Shares as of July 2, 2021, not 7,200 Restricted Shares as reported in the original Form 4. No other changes have been made to the original Form 4.